Who invested in Adaptive Biotechnologies?
Adaptive Biotechnologies's investors include Viking Global, Rock Springs Capital, Tiger Management Corporation, Matrix Capital and Senator Investment Group.
United States · Series F startup
6 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$407Mraised across 6 rounds since 2013, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $195M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $96M sold, first sale Jan 2015
From a historical funding recordSEC filing: $105M sold, first sale Apr 2014
No investor was named in the report.
From a historical funding recordSEC filing: $105M sold, first sale Apr 2014
No investor was named in the report.
Reported by genomeweb.comSEC filing: $5.0M sold, first sale Jul 2013
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Jul 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Adaptive Biotechnologies's investors include Viking Global, Rock Springs Capital, Tiger Management Corporation, Matrix Capital and Senator Investment Group.
Adaptive Biotechnologies has raised $407M across 6 rounds since 2013.
Adaptive Biotechnologies's most recent round was a Series F of $195M in May 2015.
Its most recent round, $195M in May 2015, is also its largest on record.
Adaptive Biotechnologies's first round on record, in Apr 2014, was backed by Viking Global.
Adaptive Biotechnologies's latest named round is a Series F, in May 2015.
Adaptive Biotechnologies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.